XVIVO: 12-month follow-up results from European multicenter heart trial - Redeye
Bildkälla: Stockfoto

XVIVO: 12-month follow-up results from European multicenter heart trial - Redeye

The 12-month safety results confirm and extend the earlier results after 3 months, adding support both ahead of the European, Canadian and US launch.

The 12-month safety results confirm and extend the earlier results after 3 months, adding support both ahead of the European, Canadian and US launch.
Börsvärldens nyhetsbrev